Healthcare & Pharmaceuticals
Gpr177 as a Drug Target for Cancer Treatment
Inhibition of Gpr177 poses a therapeutic solution for disorders caused by aberrant Wnt signaling cascade, such as cancer. We would like to partner with AbbVie to advance this techn ...